3 months evaluation

N = 74

After end of adjuvant treatment

N = 74

Statistical significance#

Improvement

Deterioration

Improvement

Deterioration

P value*

No (%)

No (%)

No (%)

No (%)

Breast size

13 (17.6)

3 (4.1)

13 (17.6)

2 (2.7)

0.11

Breast shape

19 (25.7)

2 (2.7)

19 (25.7)

1 (1.35)

<0.001

Scar visibility

3 (4.1)

2 (2.7)

3 (4.1)

2 (2.7)

0.66

Nipple position

10 (13.5)

1 (1.35)

10 (13.5)

Zero (0)

0.002

Skin color

4 (5.4)

1 (1.35)

4 (5.4)

Zero (0)

0.046

Donor site

74 (100)

Zero (0)

74 (100)

Zero (0)

<0.001